NCT05919264 2026-04-09
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Phase 1/2 Recruiting
Clinical Trials
9 trialsNCT05233397 2026-04-08
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Nationwide Children's Hospital
Phase 2 Recruiting
NCT05286788 2026-04-08
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Nationwide Children's Hospital
Phase 2 Recruiting
NCT05465174 2026-03-09
PNOC029
University of California, San Francisco
Phase 2 Recruiting
NCT06970145 2025-11-18
Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Nanfang Hospital, Southern Medical University
Phase 1/2 Recruiting
NCT07177482 2025-09-17
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
Beijing Tiantan Hospital
Phase NA Recruiting
NCT06299891 2025-07-28
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Seattle Children's Hospital
Phase 2 Recruiting
NCT04087902 2025-07-03
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
Recruiting
NCT06874426 2025-04-23
Endo-Olfact
Universitaire Ziekenhuizen KU Leuven
Recruiting